Home>
Stocks>
Pharma Stocks

Pharma Stocks

Name: Best Pharma Stocks - Pharma Sector Stocks to Buy
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Pharmaceutical companies manufacture drugs that are used in medicines to cure illness ranging from cancer to a common cold. India has some of the world's largest pharmaceutical companies who have a strong reputation for mass producing generic drugs.

Live Share Market

List of Pharma Stocks

Pharma Stocks

More Collections >

The Pharma Stocks collection features companies involved in the research, development, manufacturing, and distribution of pharmaceuticals. This sector is characterized by high R&D expenditures, a focus on innovation, and the potential for substantial profit margins.

More Collections >

Filter

Reset Filter

Price

Market Cap

Last 1 Yr return

Analyst Recommendation

Dividend Yield

Index

Reset Filter

Apply

Name	Price	M Cap	Analyst Rating	Target Price	Alpha	1Y Return	3Y Return	5Y Return	PE	Industry PE	PB	Beta	Div Yld	Net Profit Qtr	Net Profit QoQ %	Net Profit YoY %	Net Profit 3Y Change %	Rev Qtr (in Cr)	Rev QoQ (in %)	Rev 1Y change %	Rev 3Y change %	Profit Mar Qtr	Profit Mar QoQ	Profit Mar 1Y Change%	Profit Mar 3Y Change%	Sector	M Cap	ROE	ROCE	EPS	Volume
Sun Pharmaceuticals Industries Ltd	₹1,732.35	Large Cap	BUY	2056.16	7.71%	12.87%	91.27%	384.96%	36.64	51.23	16.41	0.6	0.83%	2917.54 Cr	-3.73%	12.7%	322.31%	13436.94	1.3%	10.51%	44.77%	19.89%	-4.97%	1.99%	191.7%	Basic Materials	419355.77	12.05%	12.22%	40.21	2167448
Divis Laboratories Ltd	₹5,818.10	Large Cap	HOLD	5824.32	61.1%	67.47%	29.55%	208.56%	74.15	51.23	6.75	0.61	0.87%	589 Cr	15.49%	-12.28%	-19.37%	2319	-0.81%	1%	12.56%	20.4%	16.44%	-13.15%	-28.37%	Basic Materials	153253.68	12.04%	16.27%	60.38	231264
Cipla Ltd	₹1,499.15	Large Cap	BUY	1642.97	-2.17%	5.08%	43.64%	302.63%	24.42	51.23	4.31	0.49	0.87%	1583.72 Cr	21.26%	46.55%	73.04%	6961.6	0.01%	13.28%	34.52%	16.12%	21.26%	29.37%	28.64%	Basic Materials	121840.83	15.5%	20.1%	51.47	1015731
Torrent Pharmaceuticals Ltd	₹3,191.30	Large Cap	BUY	3623.21	18.5%	25.35%	126.93%	253.9%	56.98	51.23	12.89	0.47	1.08%	503 Cr	11.04%	33.02%	32.31%	2762	-2.44%	11.51%	34.02%	15.44%	13.81%	19.28%	-1.28%	Basic Materials	106121.57	20.43%	20.4%	48.94	358238
Dr Reddys Laboratories Ltd	₹1,172.10	Large Cap	HOLD	1339.08	-11.77%	-5.16%	45.28%	121.75%	18.04	51.23	4.22	0.51	0.65%	1404.2 Cr	4.64%	23.75%	185.81%	8358.6	4.27%	13.54%	47.06%	19.91%	0.35%	8.99%	94.35%	Basic Materials	97105.57	19.42%	25.4%	66.88	1507415
Lupin Ltd	₹2,060.95	Large Cap	BUY	2303.17	22.5%	29.58%	169.44%	220.42%	32.34	51.23	3.58	0.57	0.49%	858.86 Cr	-0.07%	332.35%	57.63%	5618.56	2.21%	20.25%	31.97%	9.67%	-2.23%	259.55%	19.44%	Basic Materials	92890.1	11.92%	13.96%	42.47	337699
Zydus Lifesciences Ltd	₹909.90	Large Cap	HOLD	1065.77	-12.52%	-6.98%	146.22%	266.95%	20.03	51.23	6.43	0.82	0.3%	1004.3 Cr	11.82%	92.98%	80.31%	5123.5	0.19%	13.4%	35.71%	19.72%	11.61%	70.18%	32.86%	Basic Materials	90777.4	23.45%	22.73%	38.31	2142040
Mankind Pharma Ltd	₹2,161.70	Large Cap	BUY	2804.5	-3.44%	1.92%	50.87%	50.87%	42.15	51.23	9.56	0.46	NA	384.52 Cr	-41.64%	48.26%	50.17%	3230	4.99%	18.12%	66.3%	18.79%	-44.41%	25.52%	-9.7%	Pharmaceuticals	88531.1	20.95%	25.77%	48.47	1057646
Aurobindo Pharma Ltd	₹1,163.80	Mid Cap	BUY	1498.21	8.2%	14.8%	67.35%	228.61%	19.03	51.23	3.24	0.68	0.41%	845.57 Cr	3.5%	64.4%	-40.59%	7893.15	3.23%	16.68%	17.06%	10.93%	0.27%	40.89%	-49.25%	Basic Materials	66621.22	10.35%	11.74%	54.09	665708
Abbott India Ltd	₹30,348.90	Mid Cap	BUY	29838.57	0.41%	5.09%	72.34%	124.4%	0	51.23	15.48	0.41	NA	0 Cr	0%	16.35%	0%	NA	0%	14.52%	0%	14.18%	0%	1.6%	0%	Basic Materials	63179.86	34.88%	44.71%	35.67	12242
Alkem Laboratories Ltd	₹4,851.80	Mid Cap	HOLD	5384.52	-6.85%	-1.26%	37.57%	120.89%	26.71	51.23	5.6	0.52	0.81%	640.79 Cr	-8.71%	79.92%	11.97%	3374.28	-1.18%	9.21%	42.89%	14.3%	-7.62%	64.75%	-21.64%	Basic Materials	57517.94	17.56%	17.28%	151.52	60266
Glaxosmithkline Pharmaceuticals Ltd	₹2,838.30	Mid Cap	BUY	2617.75	38.19%	43.15%	77.23%	134.59%	55.49	51.23	18.45	0.61	1.65%	229.88 Cr	-8.96%	-3.39%	64.72%	949.42	-6.07%	6.21%	18.05%	17.08%	-3.08%	-9.04%	39.54%	Basic Materials	47351.53	36.83%	44.44%	34.83	127582

Why to invest in Pharma Stocks

Research and Development Focus: Pharma stocks are driven by a strong emphasis on research and development for the creation of innovative drugs.
Global Health Impact: Investing in pharma stocks aligns with contributing to global health and addressing medical challenges.
Stable Revenue Streams: These stocks often provide stable revenues due to consistent demand for medications and healthcare solutions.
Regulatory Resilience: Pharma stocks showcase resilience to regulatory changes, contributing to a stable investment environment.
Defensive Characteristics: Considered defensive, pharma stocks can offer stability during economic downturns.

Advantages of investing in Pharma Stocks

Innovation and Breakthroughs
Pharma stocks offer exposure to companies at the forefront of medical innovation, driving breakthrough treatments and advancements.
Global Health Trends
Investing in pharma stocks aligns with addressing global health challenges, positioning these stocks for sustained long-term growth.
Regulatory Stability
Pharma stocks demonstrate resilience to regulatory changes, providing a stable investment environment for investors seeking predictability in the sector.

Points to consider before investing in Pharma Stocks

Regulatory Environment
Assess the regulatory landscape affecting pharma stocks to understand potential impacts on operations and financials.
Pipeline of Innovation
Examine the innovation pipeline of pharma companies, assessing their potential for developing new drugs and medical technologies.
Financial Health
Thoroughly analyze the financial health of healthcare companies, considering factors like revenue growth, profitability, and debt levels.
Demographic Trends:
Consider demographic trends and their influence on healthcare needs, as an aging population often leads to increased demand for medical services.
Competition and Market Position
Evaluate the competitive landscape and market positioning of pharma stocks to identify companies with a strong foothold in the industry
Global Health Issues
Stay informed about global health issues, as they can significantly impact the demand for healthcare services and pharmaceuticals, influencing the performance of pharma stocks.

Check More Stocks

Name	Price	Analyst Rating	M Cap	Target Price	Alpha	1Y Return	3Y Return	5Y Return	PE	Industry PE	PB	Beta	Net Profit Qtr	Net Profit QoQ %	Net Profit YoY %	Net Profit 3Y Change %	Rev Qtr (in Cr)	Rev QoQ (in %)	Rev 1Y change %	Rev 3Y change %	Profit Mar Qtr	Profit Mar QoQ	Profit Mar 1Y Change%	Profit Mar 3Y Change%	Sector	M Cap	ROE	ROCE	EPS	Volume
Adani Power Ltd	₹521.00	BUY	LARGE CAP	630	-6.03%	-0.4%	314.41%	1811.67%	16.01	23.78	6.88	1.53	2940.07 Cr	-10.84%	94.18%	1540.09%	13671.18	2.49%	29.86%	92.02%	41.37%	-13.01%	49.53%	754.11%	Utilities	199075.9	55.41%	30.81%	54	3634978
Tata Motors Ltd	₹682.25	BUY	LARGE CAP	849.57	-33.6%	-29%	58.91%	832.21%	8.05	32.31	12.63	1.14	5578 Cr	61.68%	1082.46%	-344.36%	112833	12.23%	26.58%	75.32%	7.26%	44.06%	834.16%	-239.39%	Consumer Cyclical	250339.27	19.5%	14.69%	82.99	9338414
Adani Wilmar Ltd	₹255.10	BUY	MID CAP	334.17	-29.98%	-26%	-36.58%	-7.5%	27.06	124.45	5.04	1.04	393.16 Cr	39.46%	-69.17%	-73.83%	16859.31	16.59%	-11.9%	38.21%	0.33%	19.61%	-65.01%	-81.06%	Edible Oil	32248.93	3.42%	9.6%	1.31	1733594
Infosys Ltd	₹1,586.55	BUY	LARGE CAP	2059.62	-3.11%	3.07%	-13.15%	195%	24.1	33.09	7.66	0.76	6822 Cr	4.7%	8.88%	35.14%	41764	1.9%	4.7%	52.95%	17.08%	2.75%	3.99%	-11.64%	Technology	668320.21	36.58%	45.07%	63.37	7387068
Tata Steel Ltd	₹158.60	BUY	LARGE CAP	150	-0.22%	3.97%	18.7%	468.81%	70.62	23.04	1.43	1.36	295.49 Cr	-61.06%	-160.8%	-159.95%	53231.28	-0.48%	-5.83%	46.63%	-2.14%	-60.87%	-164.56%	-140.88%	Industrials	193070.23	7.79%	13.67%	-3.94	66161413
Yes Bank Ltd	₹17.03	SELL	MID CAP	16.55	-33.42%	-28.37%	26.95%	-69.47%	23.15	14.54	1.62	1.18	619.38 Cr	9.32%	74.66%	-136.84%	9416.05	2.07%	23.98%	42.4%	3.9%	7.1%	40.88%	-125.87%	Financial Services	51545.55	2.45%	NA	0.45	99766469
Zomato Ltd	₹223.53	BUY	LARGE CAP	285.97	34.35%	38.14%	171.38%	73.17%	287.09		6.95	0.97	59 Cr	-66.48%	-136.15%	-142.99%	5405	12.63%	71.13%	507.58%	2.9%	-70.24%	-121.12%	-107.08%	Technology	210561	5.15%	5.18%	0.4	65519150
ITC Ltd	₹403.05	BUY	LARGE CAP	517.15	0.06%	-0.11%	67.32%	152.76%	26.35	25.49	7.41	0.7	5013.18 Cr	-0.82%	6.54%	55.06%	18580.36	-6.35%	-0.08%	43.85%	29.28%	5.91%	6.63%	7.79%	Consumer Defensive	511925.48	29.21%	37.4%	15.722556476331	12830387
Wipro Ltd	₹265.70	HOLD	LARGE CAP	292.44	-1.12%	5.59%	-12.92%	221.82%	22.01	33.09	4.34	1.07	3366.7 Cr	4.34%	-2.24%	2.25%	22318.8	0.08%	-0.8%	44.93%	12.38%	4.26%	-1.45%	-29.45%	Technology	273574.06	15.13%	19.03%	10.6352127042541	14044300
HDFC Bank Ltd	₹1,744.10	BUY	LARGE CAP	1992.07	16.26%	19.52%	16.53%	93.42%	18.96	14.54	2.5	0.87	17656.61 Cr	-0.95%	39.27%	101.24%	112193.94	-7.63%	99.35%	161.73%	15.7%	7.23%	-30.13%	-23.11%	Financial Services	1325369.6	16.88%	NA	86.15	7610703

Frequently Asked Questions

What are pharma stocks?

Pharma stocks represent publicly traded companies involved in researching, developing, manufacturing, and marketing pharmaceutical drugs and treatments. These companies play a vital role in advancing healthcare and stand to benefit from successful product launches and growing healthcare needs.

What are the risks of pharma stocks?

High R&D Costs: Developing new drugs is expensive and time-consuming, with a high risk of failure during clinical trials, potentially impacting stock prices.
Regulatory Hurdles: Strict government regulations can delay drug approvals, hindering a company's ability to bring products to market.
Patent Expiry: Once a drug's patent expires, generic competition can significantly reduce profitability.
Economic Downturns: Healthcare spending can be impacted by economic downturns, potentially affecting pharma companies' revenues

How to identify promising pharma stocks?

Strong R&D Pipeline: Look for companies with a robust pipeline of drugs in various stages of development.
Focus on Innovation: Companies prioritising innovative therapies or addressing unmet medical needs can be attractive.
Financials: Evaluate a company's financial health, considering factors like profitability, debt levels, and cash flow.
Regulatory Environment: Understanding the regulatory landscape in the company's target markets is crucial.

Is diversification important when investing in Pharmaceuticals Sector Stocks?

Diversification is crucial when investing in pharmaceutical sector stocks. While the industry presents significant growth opportunities, it also entails considerable risks and uncertainties, including patent expirations, regulatory hurdles, and potential clinical trial failures, among others.

By spreading investments across multiple pharmaceutical companies, investors can mitigate risk and lessen the potential negative impact on overall returns. This approach allows for a balance between potential gains and losses, ultimately improving the performance and stability of returns.

How do changes in government policies and regulations affect pharmaceutical sector stocks?

Government policy changes can have a significant impact on pharmaceutical sector stocks. In particular, government decisions related to reimbursement rates, intellectual property rights, and drug pricing can greatly influence the market potential and profitability of pharmaceutical companies.

Explore Stocks Category:

INDmoney is 100% Safe and Secure!

Your security and privacy are our top priority!

27001:2022
ISO Certified
Audited by
cert-in empanelled auditors
AES 256-BIT
SSL Secured

Your personal information is protected.

With AES 256-bit encryption and TLS 1.3 secure data in transit.